scorecardresearch
Sunday, Oct 02, 2022
Premium

COVID-19 testing capacity mostly dependent on foreign firms

An examination of procurement and company approvals shows that foreign firms account for the largest chunk of company approvals for COVID-19 diagnostic materials in the country.

coronavirus, covid-19, coronavirus testing, coronavirus testing kits, covid-19 testing kits, indian express According to the Central Drugs Standard Control Organisation (CDSCO) list released on Wednesday, 85 of 95 (close to 90 per cent) approved antibody test kit manufacturers are foreign companies. (Source: Getty Images)

India’s testing capacity continues to be majorly reliant on global supply chains even as domestic manufacturing of other COVID-19-related requirements has been rapidly ramped up.

An examination of procurement and company approvals shows that foreign firms account for the largest chunk of company approvals for COVID-19 diagnostic materials in the country.

Don’t miss from Explained | India lockdown, other lockdowns

According to the Central Drugs Standard Control Organisation (CDSCO) list released on Wednesday, 85 of 95 (close to 90 per cent) approved antibody test kit manufacturers are foreign companies. Similarly, 11 out of 21 (more than 50 per cent) ICMR-approved RT-PCR manufacturers are foreign. Sixty per cent of the approved rapid antibody test manufacturers are Chinese.

Subscriber Only Stories
From The Explained editor: The ban on PFI, forests at night, and free gra...Premium
From the Opinion Editor: An election for the Congress partyPremium
From Nehru to JP, the political leaders mentored by GandhiPremium
Uttarakhand resort murder: Amid questions within, BJP may revamp Dhami go...Premium

Similarly, India’s recent procurement of 35 lakh RT-PCR tests by the Department of Health Research is 90 per cent imported, according to a detailed presentation on May 1 by P D Vaghela, Secretary, Department of Pharmaceuticals and Chairman of the Empowered Group on PPEs, ventilators, etc.

Even after the Indian Council of Medical Research halted the use of antibody test kits after their faulty results, the latest approval list shows a continuing reliance on Chinese-made products.

CDSCO’s antibody testing kit approval list on April 5 featured no Indian companies, 27 Chinese ones and two Korean ones.

It is the shortage of essential components that has made India’s antibody testing capacity almost entirely reliant on foreign companies. India has begun to source these components from countries like China, where the outbreak began earlier and scientists have had the opportunity to synthesise them.

Advertisement

An official of a foreign company, which is providing RT-PCR extraction kits for the Centre and several states, told The Indian Express that the obstacle for RT-PCR kits was more infrastructural. “Other countries that have been doing this for months have an easier time scaling up than India,” he said.

Read | Under the spotlight: Gaps in law to deal with mishaps like Vizag gas leak

Among other COVID-19-related requirements, the highest imported category is N-95 masks, of which 40 per cent (1 crore of 2.49 crore units) is purchased from abroad. Second is personal protective equipment (PPEs), of which one-third (80 lakh of 2 crore) has been ordered from foreign companies.

Advertisement

“Domestic production (of PPE) was nothing before this, and now 1.87 lakh are being made every day,” said Vaghela at the May 1 press conference.

Vaghela emphasised the unprecedented levels of procurement by the government, especially for products that India has been able to source entirely domestically. All of the 1.3 lakh purchased oxygen cylinders are from Indian manufacturers, and another 5 lakh industrial oxygen cylinders will be converted into medical ones.

First published on: 08-05-2020 at 01:36:15 am
Next Story

111 more corona deaths, but record stays good on fatality, recovery rates

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement